Xiaolan Jiang

ORCID: 0000-0002-1367-5360
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Ophthalmology and Eye Disorders
  • Inflammatory mediators and NSAID effects
  • Histone Deacetylase Inhibitors Research
  • Cervical Cancer and HPV Research
  • Polyamine Metabolism and Applications
  • Salivary Gland Tumors Diagnosis and Treatment
  • Parasite Biology and Host Interactions
  • MicroRNA in disease regulation
  • Growth Hormone and Insulin-like Growth Factors
  • Genetic factors in colorectal cancer
  • Pancreatic and Hepatic Oncology Research
  • Autophagy in Disease and Therapy
  • Viral-associated cancers and disorders
  • Hypothalamic control of reproductive hormones
  • Helminth infection and control
  • Maternal and fetal healthcare
  • Heart Rate Variability and Autonomic Control
  • Cancer, Stress, Anesthesia, and Immune Response
  • Myasthenia Gravis and Thymoma
  • Ovarian function and disorders
  • Estrogen and related hormone effects
  • Gallbladder and Bile Duct Disorders
  • Maternal and Perinatal Health Interventions
  • Chromatin Remodeling and Cancer

Hebei North University
2024

Hebei General Hospital
2024

First People's Hospital of Yunnan Province
2023

Radboud University Nijmegen
2021

Radboud Institute for Molecular Life Sciences
2021

Radboud University Medical Center
2021

Khondrion (Netherlands)
2021

Eastern Hepatobiliary Surgery Hospital
2015-2018

Second Military Medical University
2015-2018

Southwest University
2014

Aggressiveness of cancers, like prostate cancer, has been found to be associated with elevated expression the microsomal prostaglandin E synthase-1 (mPGES-1). Here, we investigated whether KH176m (the active metabolite sonlicromanol), a recently discovered selective mPGES-1 inhibitor, could affect cancer cells-derived spheroid growth. We demonstrated that suppressed and growth DU145 (high expression)-derived spheroids, while it had no effect on LNCaP cell line, which low expression. By...

10.1371/journal.pone.0254315 article EN cc-by PLoS ONE 2021-07-09

Abstract Objectives Gonadotropin-releasing hormone (GnRHa) is the first choice for treatment of patients with central precocious puberty (CPP). However, effects GnRHa on endocrine system CPP patients, including insulin sensitivity, lipid level, thyroid function, bone mineral density (BMD), and testosterone (T) are currently contradictory. Therefore, long-term safety therapy remains controversial. Content A systematic literature search was performed using PubMed, Embase, Cochrane Library,...

10.1515/jpem-2023-0480 article EN Journal of Pediatric Endocrinology and Metabolism 2024-01-18

Purpose: Electrogastrogram might be altered by the autonomic nervous balance which would changed military training. Methods: Twenty freshmen were chosen randomly and had tests before, during or after training with Medtronic Polygram NetTM. The indexes analysed automatically include dominant frequency power percentage of normal gastric slow wave at fast postprandial (pre-DF, pre-DP, pre-N%, pos-DF, pos-DP, pos-N%). Results: 1. Pos-DP was higher than pre-DP before training; there no difference...

10.14309/00000434-201010001-00090 article EN The American Journal of Gastroenterology 2010-10-01
Coming Soon ...